List was last updated on
.-
- Diagnosis, Management, and Surveillance for Patients with PALB2, CHEK2, and ATM Gene Mutations.
- Fencer MG, Krupa KA, Bleich GC, Grumet S, Eladoumikdachi FG, Kumar S, Kowzun MJ, Potdevin LB.
- Clin Breast Cancer. 2023 Feb 15:S1526-8209(23)00034-4. doi: 10.1016/j.clbc.2023.02.004. Epub ahead of print.
-
- Psychological distress and decision-making factors for prophylactic bilateral mastectomy in cancer-unaffected BRCA1/2 pathogenic variant carriers.
- Isselhard A, Tüchler A, Dick J, Scherer A, Aue V, Schmutzler RK, Rhiem K.
- Psychooncology. 2023 Feb 12. doi: 10.1002/pon.6111. Epub ahead of print.
-
- Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
- Vanderwal A, Lewis J, Basil J, Atzinger C, Widmeyer K.
- J Genet Couns. 2023 Jan 15. doi: 10.1002/jgc4.1674. Epub ahead of print.
- PMID: 36642783
- PubMed abstract
- Source abstract
-
- Postmastectomy breast reconstruction for women with hereditary gastric and breast cancer syndrome.
- De Lorenzi F, Borelli F, Catapano S, Alessandri-Bonetti M, Sala P, Veronesi P.
- Eur J Cancer Prev. 2022 Dec 27. doi: 10.1097/CEJ.0000000000000780. Epub ahead of print.
- PMID: 36574282
- PubMed abstract
- Source abstract
-
- Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study.
- Dick J, Tüchler A, Brédart A, Vitinius F, Wassermann K, Rhiem K, Schmutzler RK.
- Hered Cancer Clin Pract. 2022 Dec 19;20(1):38. doi: 10.1186/s13053-022-00244-y.
-
- Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review.
- Wei X, Oxley S, Sideris M, Kalra A, Sun L, Yang L, Legood R, Manchanda R.
- Cancers (Basel). 2022 Dec 12;14(24):6117. doi: 10.3390/cancers14246117.
- Review
- Free Full Text
-
- Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
- Madan V, Mamounas EP.
- Clin Breast Cancer. 2022 Dec 7:S1526-8209(22)00271-3. doi: 10.1016/j.clbc.2022.12.003. Epub ahead of print.
-
- Insurance Coverage of Prophylactic Mastectomies: A National Review of the United States.
- Ha M, Ngaage LM, Finkelstein ER, Klein M, Yang A, Colohan SM, Nurudeen SM, Terhune JH, Slezak S, Rasko YM.
- Clin Breast Cancer. 2022 Dec 5:S1526-8209(22)00269-5. doi: 10.1016/j.clbc.2022.12.001. Epub ahead of print.
-
- Immediate Breast Reconstruction Using the Autologous Dermal Flap.
- Kaviani A, Ashraf-Ganjouei A, Vasigh M, Zand S, Patocskai E.
- J Surg Res. 2022 Nov 30;283:713-718. doi: 10.1016/j.jss.2022.11.002. Epub ahead of print.
- PMID: 36462381
- PubMed abstract
- Source abstract
-
- BIA-ALCL Epidemiological Findings From a Retrospective Study of 248 Cases Extracted from Relevant Case Reports and Series: A Systematic Review.
- Di Pompeo FS, Panagiotakos D, Firmani G, Sorotos M.
- Aesthet Surg J. 2022 Nov 29:sjac312. doi: 10.1093/asj/sjac312. Epub ahead of print.
- PMID: 36441968
- PubMed abstract
- Source abstract
-
- UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.
- Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, Antoniou AC, Cleaver R, Dabir T, Evans DG, Golightly E, Jewell R, Kohut K, Manchanda R, Murray A, Murray J, Ong KR, Rosenthal AN, Woodward ER, Eccles DM, Turnbull C, Tischkowitz M; Consensus meeting attendees, Lalloo F.
- J Med Genet. 2022 Nov 21:jmg-2022-108898. doi: 10.1136/jmg-2022-108898. Epub ahead of print.
- PMID: 36411032
- PubMed abstract
- Guideline
- Free Full Text
-
- Mastectomy with one-stage or two-stage reconstruction in breast cancer: analysis of early outcomes and patient's satisfaction.
- Angela G, Alessandro P, Alessia T, Michele M, Rossella E, Marco M, Michele T, Giuseppe Massimiliano L, Walter L, Elisabetta P, Paolo PF, Ilaria SL, Giuseppe G, Mario T.
- Updates Surg. 2022 Nov 19. doi: 10.1007/s13304-022-01416-0. Epub ahead of print.
- PMID: 36401760
- PubMed abstract
-
- Receipt of Bilateral Mastectomy Among Women With Hereditary Breast Cancer.
- Reid S, Roberson ML, Koehler K, Shah T, Weidner A, Whisenant JG, Pal T.
- JAMA Oncol. 2022 Nov 3. doi: 10.1001/jamaoncol.2022.5162. Epub ahead of print.
- PMID: 36326735
- PubMed abstract
- Source abstract
-
- Revision Rate of Direct-to-Implant Breast Reconstruction: Is it Truly a Single-Stage Reconstruction? A Single-Surgeon Experience.
- Adler N, Carmon E, Houri P.
- Aesthetic Plast Surg. 2022 Oct 28. doi: 10.1007/s00266-022-03136-7. Epub ahead of print.
- PMID: 36307562
- PubMed abstract
- Source abstract
-
- Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
- Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, Domchek SM, Evans DG, Fischerova D, Harbeck N, Kuhl C, Lemley B, Levy-Lahad E, Lambertini M, Ledermann JA, Loibl S, Phillips KA, Shimon P; ESMO Guidelines Committee.
- Ann Oncol. 2022 Oct 19:S0923-7534(22)04193-X. doi: 10.1016/j.annonc.2022.10.004. Epub ahead of print.
- PMID: 36307055
- PubMed abstract
- Guideline
- Free Full Text
-
- Why I Chose Preventive Mastectomy.
- Swirsky N.
- FORCE. Blog. 2022 Oct 3.
- Blog post
- Free Full Text
-
- ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy.
- Ferroum A, Wong SM.
- Ann Surg Oncol. 2022 Oct;29(11):6669-6670. doi: 10.1245/s10434-022-12013-1. Epub 2022 Jun 16.
- PMID: 35711015
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes.
- Comeaux JG, Culver JO, Lee JE, Dondanville D, McArthur HL, Quinn E, Gorman N, Ricker C, Li M, Lerman C.
- Mol Genet Genomic Med. 2022 Oct;10(10):e2031. doi: 10.1002/mgg3.2031. Epub 2022 Aug 25.
- PMID: 36054727
- PubMed abstract
- Source abstract
-
- Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.
- Bernstein-Molho R, Friedman E, Evron E.
- Cancers (Basel). 2022 Sep 22;14(19):4592. doi: 10.3390/cancers14194592.
- PMID: 36230512
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Getting Past the Shock of a Previvor Diagnosis and Making a Plan.
- Swirsky N.
- FORCE. Blog. 2022 Sep 21.
- Blog post
- Free Full Text
-
- Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations.
- Thompson JL, Sinco BR, McCaffrey RL, Chang AE, Sabel MS, Dossett LA, Hughes TM, Jeruss JS.
- J Surg Oncol. 2022 Sep 7. doi: 10.1002/jso.27088. Epub ahead of print.
- PMID: 36069388
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy for unaffected women with a strong family history of breast cancer.
- Willson ML, Srinivasa S, Fatema K, Lostumbo L, Carbine NE, Egger SJ, Goodwin A.
- Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD015020. doi: 10.1002/14651858.CD015020.pub2.
- Study protocol
- Free Full Text
-
- Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers.
- Corso G, Robson ME, Sacchini V.
- Ann Surg Oncol. 2022 Sep;29(9):5821-5825. doi: 10.1245/s10434-022-11913-6. Epub 2022 May 23.
- PMID: 35604619
- PubMed abstract
- Source abstract
-
- Optimal breast cancer risk reduction policies tailored to personal risk level.
- Ergun MA, Hajjar A, Alagoz O, Rampurwala M.
- Health Care Manag Sci. 2022 Sep;25(3):363-388. doi: 10.1007/s10729-022-09596-2. Epub 2022 Jun 10.
- PMID: 35687269
- PubMed abstract
- Source abstract
-
- Breast cancer in a teenage girl with BRCA mutation: A case report from a low middle-income country.
- Vohra LM, Ali D, Hashmi SA, Angez M.
- Int J Surg Case Rep. 2022 Sep;98:107513. doi: 10.1016/j.ijscr.2022.107513. Epub 2022 Aug 13.
- PMID: 36027825
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Eligibility, uptake and response to germline genetic testing in women with DCIS.
- Turza L, Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Front Oncol. 2022 Aug 26;12:918757. doi: 10.3389/fonc.2022.918757.
- PMID: 36091166
- PubMed abstract
-
- What are the considerations in patient selection and timing of risk-reducing mastectomy?
- Pederson HJ, Kurian AW, Al Hilli Z.
- Cleve Clin J Med. 2022 Aug 1;89(8):442-444. doi: 10.3949/ccjm.89a.21114.
- PMID: 35914935
- PubMed abstract
-
- Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC.
- Ohsumi S, Nakamura S, Miyata H, Watanabe C, Den H, Arai M.
- Jpn J Clin Oncol. 2022 Jul 30:hyac120. doi: 10.1093/jjco/hyac120. Epub ahead of print.
- PMID: 35905458
- PubMed abstract
- Source abstract
-
- Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire.
- Herold N, Hellmich M, Lichtenheldt F, Ataseven B, Hillebrand V, Wappenschmidt B, Schmutzler RK, Rhiem K.
- Genes (Basel). 2022 Jul 28;13(8):1357. doi: 10.3390/genes13081357.
- PMID: 36011268
- PubMed abstract
- Source abstract
-
- The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.
- Forrest LE, Forbes Shepherd R, Tutty E, Pearce A, Campbell I, Devereux L, Trainer AH, James PA, Young MA.
- J Pers Med. 2022 Jul 7;12(7):1112. doi: 10.3390/jpm12071112.
- PMID: 35887609
- PubMed abstract
- Source abstract
-
- Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management.
- Yoshimura A, Imoto I, Iwata H.
- Int J Mol Sci. 2022 Jul 5;23(13):7481. doi: 10.3390/ijms23137481.
- PMID: 35806485
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.
- Bommer C, Lupatsch J, Bürki N, Schwenkglenks M.
- Eur J Health Econ. 2022 Jul;23(5):807-821. doi: 10.1007/s10198-021-01396-9. Epub 2021 Nov 12.
- PMID: 34767113
- PubMed abstract
-
- Cancer risk-reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast).
- Carneiro VCG, Gifoni ACLVC, Mauro Rossi B, Andrade CEMDC, Lima FT, Galvão HCR, Casali da Rocha JC, Silva Barreto LSD, Ashton-Prolla P, Guindalini RSC, Farias TP, Andrade WP, Fernandes PHS, Ribeiro R, Lopes A, Tsunoda AT, Azevedo BRB, Marins CAM, Oliveira Uchôa DNA, Dos Santos EAS, Fernández Coimbra FJ, Dias Filho FA, Lopes FCO, Fernandes FG, Ritt GF, Laporte GA, Guimaraes GC, Feitosa E Castro Neto H, Dos Santos JC, de Carvalho Vilela JB, Meinhardt Junior JG, Cunha JRD, Medeiros Milhomem L, da Silva LM, Maciel LF, Ramalho NM, Leite Nunes R, Guido de Araújo R, de Assunção Ehrhardt R, Delgado Bocanegra RE, Silva Junior TC, Oliveira VR, Silva Surimã W, de Melo Melquiades M, Ribeiro HSC, Oliveira AF.
- J Surg Oncol. 2022 Jul;126(1):10-19. doi: 10.1002/jso.26812.
- PMID: 35689574
- PubMed abstract
- Source abstract
-
- Medical knowledge and information needs among women with pathogenic variants in moderate-risk genes for hereditary breast cancer attending genetic counseling at an academic hospital in Germany-A qualitative approach.
- Stracke C, Lemmen C, Rhiem K, Schmutzler R, Kautz-Freimuth S, Stock S.
- J Genet Couns. 2022 Jun;31(3):698-712. doi: 10.1002/jgc4.1536. Epub 2021 Nov 26.
- PMID: 34837291
- PubMed abstract
- Source abstract
-
- Differences in Willingness to Undergo BRCA1/2 Testing and Risk Reducing Surgery among the General Public, Cancer Patients, and Healthcare Professionals: A Large Population-Based Survey.
- Chang YJ, Cho S, Joo J, Ryu KH, Lee S, Cho J, Lim MC, Jung SY, Han JH, Lee ES, Kong SY.
- J Pers Med. 2022 May 18;12(5):818. doi: 10.3390/jpm12050818.
- PMID: 35629239
- PubMed abstract
- Source abstract
-
- Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients.
- Espinel W, Champine M, Hampel H, Jeter J, Sweet K, Pilarski R, Pearlman R, Shane K, Brock P, Westman JA, Kipnis L, Sotelo J, Chittenden A, Culver S, Stopfer JE, Schneider KA, Sacca R, Koeller DR, Gaonkar S, Vaccari E, Kane S, Michalski ST, Yang S, Nielsen SM, Bristow SL, Lincoln SE, Nussbaum RL, Esplin ED.
- Cancers (Basel). 2022 May 13;14(10):2426. doi: 10.3390/cancers14102426.
- PMID: 35626031
- PubMed abstract
- Source abstract
-
- Combining Breast and Ovarian Operations Increases Complications.
- Henn D, Barrera JA, Sivaraj D, Lin JQ, Rizk NM, Ma I, Gurtner GC, Lee GK, Nazerali RS.
- Plast Reconstr Surg. 2022 May 1;149(5):1050-1059. doi: 10.1097/PRS.0000000000008984. Epub 2022 Mar 2.
- PMID: 35245249
- PubMed abstract
- Source abstract
-
- Phylogenetic Analysis IDs Subset of De Novo Tumors Unrelated to Primary DCIS.
- Ray T.
- GenomeWeb. Disease Areas. Cancer. 2022 Apr 11.
- Conference report
- Source abstract
-
- Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
- Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, Antoniou AC, Easton DF, Engel C, Goldgar D, John EM, Kast K, Milne RL, Olsson H, Phillips KA, Terry MB, Hopper JL, van Leeuwen FE, Rookus MA.
- J Natl Cancer Inst. 2022 Apr 11;114(4):540-552. doi: 10.1093/jnci/djac004.
- PMID: 35048954
- PubMed abstract
Commentary:
Oral Contraceptives and BRCA Cancer: A Balancing Act.
- PMID: 35048983
- PubMed abstract
- Free Full Text
-
- Attitude towards hereditary cancer risk management among women with cancer in Taiwan.
- Fang SY, Hsieh LL, Hung CF, Hung FH, Peng HP, Yang AS, Wang YA.
- Support Care Cancer. 2022 Apr;30(4):3625-3632. doi: 10.1007/s00520-021-06742-4. Epub 2022 Jan 14.
- PMID: 35028717
- PubMed abstract
- Source abstract
-
- Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review.
- Simões Corrêa Galendi J, Kautz-Freimuth S, Stock S, Müller D.
- Cancers (Basel). 2022 Mar 31;14(7):1786. doi: 10.3390/cancers14071786.
- PMID: 35406563
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy.
- Bernini M, Meattini I, Saieva C, Becherini C, Salvestrini V, Visani L, Stocchi G, Bellini C, Lorenzetti V, Sordi S, Nori J, De Benedetto D, Desideri I, Bianchi S, Livi L, Orzalesi L.
- Breast Cancer. 2022 Mar;29(2):302-313. doi: 10.1007/s12282-021-01314-0. Epub 2021 Nov 14.
- PMID: 34775540
- PubMed abstract
- Source abstract
-
- Indications des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF) [Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)].
- Mathelin C, Barranger E, Boisserie-Lacroix M, Boutet G, Brousse S, Chabbert-Buffet N, Coutant C, Daraï E, Delpech Y, Duraes M, Espié M, Fornecker L, Golfier F, Grosclaude P, Hamy AS, Kermarrec E, Lavoué V, Lodi M, Luporsi É, Maugard CM, Molière S, Seror JY, Taris N, Uzan C, Vaysse C, Fritel X.
- Gynecol Obstet Fertil Senol. 2022 Feb;50(2):107-120. French. doi: 10.1016/j.gofs.2021.12.005. Epub 2021 Dec 14.
- PMID: 34920167
- PubMed abstract
- Source abstract
-
- Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li-Fraumeni syndrome.
- Siegel A, Bremer RC, Klein WMP, Savage SA, Loud JT, Khincha PP.
- Breast Cancer Res Treat. 2022 Jan;191(1):159-167. doi: 10.1007/s10549-021-06410-5. Epub 2021 Oct 15.
- PMID: 34652547
- PubMed abstract
- Source abstract
-
- Is there an increasing trend of risk-reducing prophylactic mastectomy procedure in preventing breast cancer among women?
- Arslan B, Tazeoglu D, Dag A, Berkesoglu M, Özdemir AA.
- Turk J Surg. 2021 Dec 31;37(4):347-354. doi: 10.47717/turkjsurg.2021.4963.
- PMID: 35677477
- PubMed abstract
- Source abstract
-
- Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial.
- Landau C, Novak AM, Ganz AB, Rolnik B, Friedman E, Lev-Ari S.
- JAMA Netw Open. 2021 Dec 1;4(12):e2139670. doi: 10.1001/jamanetworkopen.2021.39670.
- PMID: 34962562
- PubMed abstract
-
- Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer.
- Evans DG, Gandhi A, Wisely J, Clancy T, Woodward ER, Harvey J, Highton L, Murphy J, Barr L, Howell SJ, Lalloo F, Harkness EF, Howell A.
- Breast. 2021 Dec;60:45-52. doi: 10.1016/j.breast.2021.08.015. Epub 2021 Aug 26.
- PMID: 34464846
- PubMed abstract
-
- Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
- Marmolejo DH, Wong MYZ, Bajalica-Lagercrantz S, Tischkowitz M, Balmaña J; extended ERN-GENTURIS Thematic Group 3.
- Eur J Med Genet. 2021 Dec;64(12):104350. doi: 10.1016/j.ejmg.2021.104350. Epub 2021 Oct 1.
- PMID: 34606975
- PubMed abstract
- Source abstract
-
- Bilateral Risk-Reducing Prophylactic Mastectomies in an Unaffected BRCA1 Carrier Using Dermal Sling and Implant.
- Gupta S, Kadayaprath G, Gupta N, Barthwal V.
- Indian J Surg Oncol. 2021 Dec;12(Suppl 2):355-358. doi: 10.1007/s13193-021-01370-0. Epub 2021 Jun 16.
- PMID: 35035170
- PubMed abstract
- Source abstract
-
- Breast Cancer Surgery: New Issues.
- Magnoni F, Alessandrini S, Alberti L, Polizzi A, Rotili A, Veronesi P, Corso G.
- Curr Oncol. 2021 Oct 11;28(5):4053-4066. doi: 10.3390/curroncol28050344.
- PMID: 34677262
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Prepectoral breast reconstruction: an ideal approach to bilateral risk-reducing mastectomy.
- Maruccia M, Elia R, Tedeschi P, Gurrado A, Moschetta M, Testini M, Giudice G.
- Gland Surg. 2021 Oct;10(10):2997-3006. doi: 10.21037/gs-21-339.
- PMID: 34804886
- PubMed abstract
-
- Data on Utility in Cost-Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer.
- Simões Corrêa Galendi J, Vennedey V, Kentenich H, Stock S, Müller D.
- Cancers (Basel). 2021 Sep 29;13(19):4879. doi: 10.3390/cancers13194879.
- PMID: 34638366
- PubMed abstract
- Source abstract
-
- Bilateral DIEP flap breast reconstruction with simultaneous unilateral nipple-sparing mastectomy - case report.
- Lukasz U, Piotr G, Maria M.
- Folia Med Cracov. 2021 Sep 29;61(3):115-124. doi: 10.24425/fmc.2021.138955.
- PMID: 34882668
- PubMed abstract
- Journal
-
- Surgical Management of Hereditary Breast Cancer.
- Berger ER, Golshan M.
- Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371.
- PMID: 34573353
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- ASO Author Reflections: Prophylactic Nipple-Sparing Mastectomy as an Effective Risk-Reducing Strategy for BRCA Mutation Carriers.
- Garstka M, Smith BL.
- Ann Surg Oncol. 2021 Aug 13. doi: 10.1245/s10434-021-10588-9. Epub ahead of print.
- PMID: 34387770
- PubMed abstract
- Source abstract
-
- Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.
- Park B, Kim D, Kim J, Lee BY, Yoon J, Kim SW.
- Cancer Res Treat. 2021 Aug 9. doi: 10.4143/crt.2021.449. Epub ahead of print.
- PMID: 34384016
- PubMed abstract
- Source abstract
-
- Surgical management of BRCA pathogenic variant carriers with breast cancer: a recent literature review and current state of the art.
- Terribile DA, Mason EJ, Murando F, DI Leone A, Sanchez AM, Scardina L, Magno S, Franco A, D'Archi S, Natale M, Lucci Cordisco E, Masetti R, Franceschini G.
- Minerva Surg. 2021 Aug 2. doi: 10.23736/S2724-5691.21.09009-2. Epub ahead of print.
- PMID: 34338470
- PubMed abstract
- Source abstract
-
- Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.
- Wei G, Kumar A, Lee MC, Wang X.
- Clin Breast Cancer. 2021 Aug;21(4):e427-e433. doi: 10.1016/j.clbc.2021.01.008. Epub 2021 Jan 19.
- PMID: 33712364
- PubMed abstract
- Source abstract
-
- Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
- Tischkowitz M, Balmaña J, Foulkes WD, James P, Ngeow J, Schmutzler R, Voian N, Wick MJ, Stewart DR, Pal T; ACMG Professional Practice and Guidelines Committee.
- Genet Med. 2021 Aug;23(8):1416-1423. doi: 10.1038/s41436-021-01151-8. Epub 2021 May 11.
- PMID: 33976419
- PubMed abstract
- Source abstract
-
- Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs).
- Plangger A, Haslik W, Rath B, Neumayer C, Hamilton G.
- J Mammary Gland Biol Neoplasia. 2021 Jul 6. doi: 10.1007/s10911-021-09493-4. Epub ahead of print.
- PMID: 34228231
- PubMed abstract
-
- Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.
- Safra T, Waissengrin B, Gerber D, Bernstein-Molho R, Klorin G, Salman L, Josephy D, Chen-Shtoyerman R, Bruchim I, Frey MK, Pothuri B, Muggia F.
- Gynecol Oncol. 2021 Jun 22:S0090-8258(21)00489-3. doi: 10.1016/j.ygyno.2021.06.009. Epub ahead of print.
- PMID: 34172288
- PubMed abstract
- Source abstract
-
- Why I’m Choosing to Keep My Breasts (For Now).
- Kingery R.
- FORCE. Blog. 2021 Jun 11.
- Blog post
- Free Full Text
-
- Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021.
- Xie F, Wang S.
- Chin Med J (Engl). 2021 Jun 4;134(13):1516-1518. doi: 10.1097/CM9.0000000000001587.
- PMID: 34091527
- PubMed abstract
- Guideline
- Free PMC article
- Free Full Text
-
- An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
- Kotsopoulos J, Kim SJ, Armel S, Bordeleau L, Foulkes WD, McKinnon W, Panchal S, Cohen SA, Sun S, Sun P, McKetton L, Troyer AK, Narod SA.
- Cancer. 2021 Jun 2. doi: 10.1002/cncr.33654. Epub ahead of print.
- PMID: 34077552
- PubMed abstract
- Source abstract
-
- Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained.
- Ben David MA, Evron E, Rasco AF, Shai A, Corn BW.
- Cancers (Basel). 2021 May 30;13(11):2694. doi: 10.3390/cancers13112694.
- PMID: 34070748
- PubMed abstract
- Source abstract
-
- Evaluation of online Spanish and English health materials for preventive mastectomy. are we providing adequate information?
- Del Valle DD, Pardo JA, Maselli AM, Valero MG, Fan B, Seyidova N, James TA, Lee BT.
- Breast Cancer Res Treat. 2021 May;187(1):1-9. doi: 10.1007/s10549-021-06171-1. Epub 2021 Mar 15.
- PMID: 33721147
- PubMed abstract
- Source abstract
-
- Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.
- Toss A, Tenedini E, Piombino C, Venturelli M, Marchi I, Gasparini E, Barbieri E, Razzaboni E, Domati F, Caggia F, Grandi G, Combi F, Tazzioli G, Dominici M, Tagliafico E, Cortesi L.
- Genes (Basel). 2021 Apr 21;12(5):616. doi: 10.3390/genes12050616.
- PMID: 33919281
- PubMed abstract
- Source abstract
-
- Management of patients with BRCA mutation from the point of view of a breast surgeon.
- Riis ML.
- Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
- PMID: 33996049
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.
- Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA.
- Clin Genet. 2021 Apr 12. doi: 10.1111/cge.13966. Epub ahead of print.
- PMID: 33843052
- PubMed abstract
- Free Full Text
-
- Controversies in Hereditary Cancer Management.
- AlHilli MM, Pederson HJ.
- Obstet Gynecol. 2021 Apr 8. doi: 10.1097/AOG.0000000000004364. Epub ahead of print.
- PMID: 33831930
- PubMed abstract
- Source abstract
-
- Bilateral nipple-sparing mastectomy and breast reconstruction in BRCA1 mutation-positive simultaneous bilateral breast cancer: A case study.
- Yoneyama K, Nakagawa M, Hara A.
- Int J Surg Case Rep. 2021 Apr;81:105788. doi: 10.1016/j.ijscr.2021.105788. Epub 2021 Mar 17.
- PMID: 33756165
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Understanding Breast Implant Risks.
- Spittal K.
- FORCE. XRAY. 2021 Mar 30.
- Blog post
- Free Full Text
-
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
- Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC, Karlan BY, Khan S, Klein C, Kohlmann W; CGC, Kurian AW, Laronga C, Litton JK, Mak JS; LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC, Senter-Jamieson L; CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA.
- J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
- PMID: 33406487
- PubMed abstract
- Source abstract
- Guidelines
- Free Full Text
-
- Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.
- Cardoso F, MacNeill F, Penault-Llorca F, Eniu A, Sardanelli F, Nordström EB, Poortmans P.
- Breast. 2021 Jan 2;55:128-135. doi: 10.1016/j.breast.2020.12.010. Epub ahead of print.
- PMID: 33461060
- PubMed abstract
-
- Genetic Testing Challenges in Oncology: Woman Without High Breast Cancer Risk Recommended Surgery.
- Ray T.
- Precision Oncology News. 2020 Dec 22.
- Case report
- Free Full Text
-
- My Previvor Journey: My Robotic Mastectomy.
- Mallonee R.
- FORCE. Blog. 2020 Dec 7.
- Blog post
- Free Full Text
-
- Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants.
- Leitsalu L, Palover M, Sikka TT, Reigo A, Kals M, Pärn K, Nikopensius T, Esko T, Metspalu A, Padrik P, Tõnisson N.
- Eur J Hum Genet. 2020 Nov 23. doi: 10.1038/s41431-020-00760-2. Epub ahead of print.
- PMID: 33230308
- PubMed abstract
- Source abstract
-
- Expanded Panel Testing Uncovered My ATM Mutation.
- Horton M.
- FORCE. Blog. 2020 Nov 23.
- Blog post
- Free Full Text
-
- I am a PALB2 Previvor.
- Dinschel A.
- FORCE. Blog. 2020 Nov 19.
- Blog post
- Free Full Text
-
- Population-Wide Hereditary Breast, Ovarian Cancer Screening in Younger Women is Cost-Effective.
- [No author given]
- Clinical OMICs. Molecular Dx. 2020 Nov 17.
- Research news
- Free full Text
Original research:
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
- PMID: 33119106
- PubMed abstract
- Free Full Text
-
- Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique.
- Toh U, Takenaka M, Iwakuma N, Akagi Y.
- Surg Today. 2020 Nov 13. doi: 10.1007/s00595-020-02175-4. Epub ahead of print.
- PMID: 33185799
- PubMed abstract
- Review
- Free Full Text
-
- Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series.
- D'Abbondanza JA, George R, Kives S, Musgrave MA.
- Plast Surg (Oakv). 2020 Nov;28(4):243-248. doi: 10.1177/2292550320928551. Epub 2020 Jun 4.
- PMID: 33215039
- PubMed abstract
- Source abstract
-
- Knowing about an inherited BRCA mutation improves outcomes for women with breast cancer.
- [No author given]
- FORCE. XRAY. 2020 Oct 26.
- Research news
- Free Full Text
Original research:
Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.
- PMID: 32644100
- PubMed abstract
- Free Full Text
-
- Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations.
- Pouptsis A, Swafe L, Patwardhan M, Stavraka C.
- Front Oncol. 2020 Oct 20;10:553080. doi: 10.3389/fonc.2020.553080. PMID: 33194613; PMCID: PMC7607003.
- PMID: 33194613
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
- Guzauskas GF, Garbett S, Zhou Z, Spencer SJ, Smith HS, Hao J, Hassen D, Snyder SR, Graves JA, Peterson JF, Williams MS, Veenstra DL.
- JAMA Netw Open. 2020 Oct 1;3(10):e2022874. doi: 10.1001/jamanetworkopen.2020.22874.
- PMID: 33119106
- PubMed abstract
Press: Population-Wide Hereditary Breast, Ovarian Cancer Screening in Younger Women is Cost-Effective. (Clinical OMICs)
-
- Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.
- Galmor L, Bernstein-Molho R, Sklair-Levy M, Madoursky-Feldman D, Zippel D, Laitman Y, Friedman E.
- Breast Cancer Res Treat. 2020 Sep 30. doi: 10.1007/s10549-020-05949-z. Epub ahead of print.
- PMID: 33000375
- PubMed abstract
- Source abstract
-
- Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation.
- Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Narod SA, Evans DG, Liede A.
- Hered Cancer Clin Pract. 2020 Sep 29;18:20. doi: 10.1186/s13053-020-00152-z.
- PMID: 33014209
- PubMed abstract
-
- Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.
- Hadar T, Mor P, Amit G, Lieberman S, Gekhtman D, Rabinovitch R, Levy-Lahad E.
- JAMA Oncol. 2020 Sep 1;6(9):1460-1463. doi: 10.1001/jamaoncol.2020.2059.
- PMID: 32644100
- PubMed abstract
- Source abstract
Research news: Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis. (GenomeWeb)
Research news: 'Knowledge Is Power': Knowing BRCA1/2 Status Tied to Survival. (Medscape)
Research news: Knowing about an inherited BRCA mutation improves outcomes for women with breast cancer. (FORCE. XRAY.)
-
- Management of early breast cancer during the COVID-19 pandemic in Brazil.
- Cavalcante FP, Novita GG, Millen EC, Zerwes FP, de Oliveira VM, Sousa ALL, Freitas Junior R.
- Breast Cancer Res Treat. 2020 Aug 16. doi: 10.1007/s10549-020-05877-y. Epub ahead of print.
- PMID: 32803637
- PubMed abstract
-
- Risk for breast cancer and management of unaffected individuals with non-BRCA hereditary breast cancer.
- Wood ME, McKinnon W, Garber J.
- Breast J. 2020 Aug 2. doi: 10.1111/tbj.13969. Epub ahead of print.
- PMID: 32741080
- PubMed abstract
- Source abstract
-
- Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- Goncalves R.
- Breast Cancer Res Treat. 2020 Aug;182(3):763-764. doi: 10.1007/s10549-020-05742-y. Epub 2020 Jun 13.
- PMID: 32535766
- PubMed abstract
- Source abstract
Original research:
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- PMID: 32215763
- PubMed abstract
- Source abstract
-
- Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.
- Collins JM, Isaacs C.
- Breast J. 2020 Jul 11. doi: 10.1111/tbj.13970. Epub ahead of print.
- PMID: 32652823
- PubMed abstract
- Source abstract
-
- How to Prepare for a Mastectomy Amid COVID and Other Life Events.
- Wheaton J.
- FORCE Blog. 2020 Jul 8.
- Blog post
- Free Full Text
-
- Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
- Cragun D, Weidner A, Tezak A, Clouse K, Pal T.
- Breast Cancer Res Treat. 2020 Jul;182(2):421-428. doi: 10.1007/s10549-020-05699-y. Epub 2020 May 22.
- PMID: 32445176
- PubMed abstract
- Source abstract
-
- Study: What is the risk for contralateral breast cancer in women with an inherited BRCA1, BRCA2 or TP53 mutation?
- [No author given]
- FORCE. XRAYS. 2020 Jun 6.
- Research news
- Free Full Text
Original research:
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer.
- PMID: 32045981
- PubMed abstract
- Free Full Text
-
- The DIEP Flap as Well-established Method of Choice for Autologous Breast Reconstruction with a Low Complication Rate - Retrospective Single-centre 10-Year Experience.
- Munder B, Andree C, Witzel C, Fertsch S, Stambera P, Schulz T, Fleischer O, Hagouan M, Grüter L, Aufmesser B, Staemmler K, Kornetka J, Aldeeri M, Seidenstücker K, Abu-Ghazaleh A, Wolter A.
- Geburtshilfe Frauenheilkd. 2020 Jun;80(6):628-638. doi: 10.1055/a-1116-2102. Epub 2020 Apr 16.
- PMID: 32565553
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- Frasson AL, Lichtenfels M, de Souza AAB, Vollbrecht B, Falcone AB, Frasson MARM, Barbosa F.
- Breast Cancer Res Treat. 2020 May;181(1):69-75. doi: 10.1007/s10549-020-05582-w. Epub 2020 Mar 25.
- PMID: 32215763
- PubMed abstract
- Source abstract
Letter, Commentary:
Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- PMID: 32535766
- PubMed abstract
- Source abstract
-
- Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
- Hurry M, Eccleston A, Dyer M, Hoskins P
- Int J Technol Assess Health Care. 2020 Apr;36(2):104-112. doi: 10.1017/S0266462319003519.
- PMID: 32423520
- PubMed abstract
- Source abstract
-
- Lumbar Flap versus the Gold Standard: Comparison to the DIEP Flap.
- Opsomer D, Vyncke T, Depypere B, Stillaert F, Blondeel P, Van Landuyt K.
- Plast Reconstr Surg. 2020 Apr;145(4):706e-714e. doi: 10.1097/PRS.0000000000006681.
- PMID: 32221200
- PubMed abstract
- Source abstract
-
- Oncoplastic Procedures in Preparation for Nipple-Sparing Mastectomy and Autologous Breast Reconstruction: Controlling the Breast Envelope.
- Momeni A, Kanchwala S, Sbitany H.
- Plast Reconstr Surg. 2020 Apr;145(4):914-920. doi: 10.1097/PRS.0000000000006657.
- PMID: 32221203
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy in germline CDH1 mutation carriers: Pathologic findings.
- Gianella CA, Bendito B, Iglesias C, Bengoechea MP, Miñón C, Ruiz A.
- Breast J. 2020 Mar;26(3):583-584. doi: 10.1111/tbj.13604. Epub 2019 Sep 20.
- PMID: 31538378
- PubMed abstract
- Source abstract
-
- Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer.
- Hyder Z, Harkness EF, Woodward ER, Bowers NL, Pereira M, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG, Smith MJ, Evans DG.
- Cancers (Basel). 2020 Feb 7;12(2):378. doi: 10.3390/cancers12020378.
- PMID: 32045981
- PubMed abstract
- Source abstract
Research news: Study: What is the risk for contralateral breast cancer in women with an inherited BRCA1, BRCA2 or TP53 mutation? (FORCE XRAYS)
-
- Bilateral Breast Reconstruction With Profunda Artery Perforator Flaps and Immediate Implant Augmentation.
- Chu CK, DeFazio M, Largo RD, Ross M.
- Aesthet Surg J Open Forum. 2020 Jan 14;2(1):ojz036. doi: 10.1093/asjof/ojz036.
- PMID: 33791635
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
- van Egdom LSE, de Kock MA, Apon I, Mureau MAM, Verhoef C, Hazelzet JA, Koppert LB.
- Breast Cancer. 2019 Dec 12. doi: 10.1007/s12282-019-01033-7. [Epub ahead of print]
- PMID: 31832891
- PubMed abstract
-
- BRCA and Motherhood: A Matter of Time and Timing.
- Possick C, Kestler-Peleg M.
- Qual Health Res. 2019 Dec 7:1049732319885113. doi: 10.1177/1049732319885113. [Epub ahead of print]
- PMID: 31814509
- PubMed abstract
- Source abstract
-
- Prophylactic nipple-sparing mastectomy in young previvors: Examining decision-making, reconstructive outcomes, and patient satisfaction in BRCA+ patients under 30.
- Salibian AA, Bekisz JM, Frey JD, Miller B, Choi M, Karp NS.
- Breast J. 2019 Nov 17. doi: 10.1111/tbj.13692. [Epub ahead of print]
- PMID: 31736224
- PubMed abstract
- Source abstract
-
- Geisinger MyCode® detects BRCA2 mutation prior to abdominal panniculectomy allowing for DIEP flap breast reconstruction.
- Kauffman CA.
- Case Reports Plast Surg Hand Surg. 2019 Nov 6;6(1):145-147. doi: 10.1080/23320885.2019.1684824. eCollection 2019.
- PMID: 32002463
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free full text
-
- Is prophylactic mastectomy justified in women without BRCA mutation?
- Rutgers EJT.
- Breast. 2019 Nov;48 Suppl 1:S62-S64. doi: 10.1016/S0960-9776(19)31126-9.
- PMID: 31839163
- PubMed abstract
- Review
- Free Full Text
-
- Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer.
- [No author given]
- National Institute for Health and Care Excellence (UK): Clinical Guidelines; 2013 Jun. [Last Update: November 2019.]
- PMID: 31940157
- PubMed abstract
- Guidelines
- Free Full Text
-
- Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy.
- Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Csorba R, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP.
- Eur J Med Res. 2019 Sep 14;24(1):32. doi: 10.1186/s40001-019-0391-8.
- PMID: 31521205
- PubMed abstract
-
- Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
- Park KU, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, Hanson SE, Candelaria R, Tevis S, Thompson A.
- Ann Surg Oncol. 2019 Aug 9. doi: 10.1245/s10434-019-07704-1. [Epub ahead of print]
- PMID: 31399819
- PubMed abstract
- Source abstract
-
- Warranting the decision-maker, not the decision: How healthcare practitioners evaluate the legitimacy of patients' unprompted requests for risk-reducing mastectomy.
- Brown SL, Beesley H, Holcombe C, Saini P, Salmon P.
- Patient Educ Couns. 2019 Aug;102(8):1446-1451. doi: 10.1016/j.pec.2019.03.007. Epub 2019 Mar 18.
- PMID: 30922623
- PubMed abstract
-
- Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
- Bercow AS, Eisenhauer EL.
- J Surg Oncol. 2019 Jul 29. doi: 10.1002/jso.25645. [Epub ahead of print]
- PMID: 31355450
- PubMed abstract
- Source abstract
-
- Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers.
- Nagura N, Hayashi N, Takei J, Yoshida A, Ochi T, Iwahira Y, Yamauchi H.
- Breast Cancer. 2019 Jul 10. doi: 10.1007/s12282-019-00995-y. [Epub ahead of print]
- PMID: 31292927
- PubMed abstract
- Source abstract
-
- Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: are there factors associated with the choice?
- Manoukian S, Alfieri S, Bianchi E, Peissel B, Azzollini J, Borreani C.
- Psychooncology. 2019 Jul 1. doi: 10.1002/pon.5166. [Epub ahead of print]
- PMID: 31264307
- PubMed abstract
- Source abstract
-
- Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers.
- Rojas KE, Butler E, Gutierrez J, Kwait R, Laprise J, Wilbur JS, Spinette S, Raker CA, Robison K, Legare R, Gass J, Stuckey A.
- Gland Surg. 2019 Jun;8(3):249-257. doi: 10.21037/gs.2019.04.08.
- PMID: 31328104
- PubMed abstract
- Source abstract
-
- Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.
- Grinstein O, Krug B, Hellmic M, Siedek F, Malter W, Burke C, Schmutzler R, Maintz D, Rhiem K.
- Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
- PMID: 31196476
- PubMed abstract
- Source abstract
-
- Factors associated with intentions for breast cancer risk management: Does risk group matter?
- Conley CC, Agnese DM, Vadaparampil ST, Andersen BL.
- Psychooncology. 2019 May;28(5):1119-1126. doi: 10.1002/pon.5066. Epub 2019 Apr 10.
- PMID: 30889627
- PubMed abstract
- Source abstract
-
- Breast cancer stalked every woman in her family. She was determined it wouldn’t get her.
- Reyes-Velarde A.
- Los Angeles Times. Column One. 2019 Apr 25.
- Press
- Free Full Text
Press: Behind the story: For a daughter of immigrants, a story stirs up memories of her own family. (Los Angeles Times)
-
- Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making.
- Franceschini G, Masetti R.
- Breast J. 2019 Apr 9. doi: 10.1111/tbj.13287. [Epub ahead of print]
- PMID: 30964221
- PubMed abstract
- Source abstract
-
- Multidisciplinary management of CDH1 germinal mutation and prophylactic management hereditary lobular breast cancer: A case report.
- Mirandola S, Pellini F, Granuzzo E, Lorenzi M, Accordini B, Ulgelmo M, Invento A, Lombardi D, Caldana M, Pollini GP.
- Int J Surg Case Rep. 2019 Apr 5;58:92-95. doi: 10.1016/j.ijscr.2019.03.053. [Epub ahead of print]
- PMID: 31028995
- PubMed abstract
- Case report
- Free Full Text
-
- What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.
- Franceschini G, Masetti R.
- Eur J Breast Health. 2019 Apr 1;15(2):135-136. doi: 10.5152/ejbh.2019.4651. eCollection 2019 Apr.
- PMID: 31001617
- PubMed abstract
- Source abstract
- Letter, Review
- Free PMC article
- Free Full Text (PDF)
Review:
Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
- PMID: 30288491
- PubMed abstract
- Source abstract
-
- Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.
- Grobmyer SR, Pederson HJ, Valente SA, Al-Hilli Z, Radford D, Djohan R, Yetman R, Eng C, Crowe JP.
- BJS Open. 2018 Nov 26;3(2):169-173. doi: 10.1002/bjs5.50117. eCollection 2019 Apr.
- PMID: 30957063
- PubMed abstract
- Source abstract
-
- Body image problems in women with and without breast cancer 6-20 years after bilateral risk-reducing surgery - A prospective follow-up study.
- Bai L, Arver B, Johansson H, Sandelin K, Wickman M, Brandberg Y.
- Breast. 2019 Apr;44:120-127. doi: 10.1016/j.breast.2019.01.013. Epub 2019 Feb 1.
- PMID: 30743225
- PubMed abstract
- Source abstract
-
- Current knowledge of risk reducing mastectomy: Indications, techniques, results, benefits, harms.
- Baildam AD.
- Breast. 2019 Mar 29;46:48-51. doi: 10.1016/j.breast.2019.03.011. [Epub ahead of print]
- PMID: 31082761
- PubMed abstract
- Source abstract
-
- Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome.
- Modaffari P, Ponzone R, Ferrari A, Cipullo I, Liberale V, D'Alonzo M, Maggiorotto F, Biglia N.
- J Clin Med. 2019 Mar 5;8(3). pii: E313. doi: 10.3390/jcm8030313.
- PMID: 30841601
- PubMed abstract
- Source abstrac
-
- Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE).
- Henry DA, Lee MC, Almanza D, Ahmed KA, Sun W, Boulware DC, Laronga C.
- Breast Cancer Res Treat. 2019 Feb;174(1):39-45. doi: 10.1007/s10549-018-5057-7. Epub 2018 Nov 24.
- PMID: 30474778
- PubMed abstract
- Source abstract
s
-
- Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery.
- Strach MC, Prasanna T, Kirova YM, Alran S, O'Toole S, Beith JM, Poortmans P, McNeil CM, Carroll S.
- Crit Rev Oncol Hematol. 2019 Feb;134:10-21. doi: 10.1016/j.critrevonc.2018.11.007. Epub 2018 Nov 30.
- PMID: 30771869
- PubMed abstract
- Source abstract
-
- Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.
- AlHilli MM, Al-Hilli Z.
- J Minim Invasive Gynecol. 2019 Feb;26(2):253-265. doi: 10.1016/j.jmig.2018.09.767. Epub 2018 Sep 19.
- PMID: 30240898
- PubMed abstract
- Source abstract
-
- 'Taking Back Control': The Growth in Prophylactic Mastectomy.
- Davenport L.
- Medscape. Medscape Oncology. 2019 Jan 10.
- News
- Free Full Text
Press: 'We've Scared Women': The Growth of Prophylactic Mastectomy (Medscape Oncology)
-
- Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion.
- Domchek SM.
- JAMA. 2019 Jan 1;321(1):27. doi: 10.1001/jama.2018.18942.
- PMID: 30521006
- PubMed abstract
- Source abstract
-
- Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
- Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
- Ann Ital Chir. 2019;90:1-2.
- PMID: 30872561
- PubMed abstract
-
- Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- Narod SA.
- JAMA Oncol. 2018 Dec 1;4(12):1787-1788. doi: 10.1001/jamaoncol.2018.4931.
- PMID: 30383137
- PubMed abstract
- Source abstract
Original Research:
Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- PMID: 29801090
- PubMed abstract
- Source abstract
Letter, reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer—Reply
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.
- D'Alonzo M, Piva E, Pecchio S, Liberale V, Modaffari P, Ponzone R, Biglia N.
- Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366. doi: 10.1016/j.clbc.2018.07.015. Epub 2018 Jul 26.
- PMID: 30122348
- PubMed abstract
- Source abstract
-
- Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.
- Ladd MK, Peshkin BN, Senter L, Baldinger S, Isaacs C, Segal H, Philip S, Phillips C, Shane K, Martin A, Weinstein V, Pilarski R, Jeter J, Sweet K, Hatten B, Wurtmann EJ, Phippen S, Bro D, Schwartz MD.
- Transl Behav Med. 2018 Nov 10. doi: 10.1093/tbm/iby101. [Epub ahead of print]
- PMID: 30418620
- PubMed abstract
-
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
- Petelin L, Trainer AH, Mitchell G, Liew D, James PA.
- Genet Med. 2018 Oct;20(10):1145-1156. doi: 10.1038/gim.2017.255. Epub 2018 Jan 11.
- PMID: 29323669
- PubMed abstract
- Source abstract
-
- The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
- Braude L, Kirsten L, Gilchrist J, Juraskova I.
- Psychooncology. 2018 Oct;27(10):2349-2356. doi: 10.1002/pon.4830. Epub 2018 Sep 4.
- PMID: 29966172
- PubMed abstract
- Source abstract
-
- Do All BRCA 1 and 2 Carriers with a Known and Unknown Breast Cancer Choose Bilateral Mastectomies?
- Gaffley M, Villa A, Vu T, Steelman S, Howard-McNatt M.
- Am Surg. 2018 Sep 1;84(9):1544-1545.
- PMID: 30268191
- PubMed abstract
- Source abstract
-
- A comparison of patient satisfaction (using the BREAST-Q questionnaire) with bilateral breast reconstruction following risk-reducing or therapeutic mastectomy.
- Kazzazi F, Haggie R, Forouhi P, Kazzazi N, Wyld L, Malata CM.
- J Plast Reconstr Aesthet Surg. 2018 Sep;71(9):1324-1331. doi: 10.1016/j.bjps.2018.06.011. Epub 2018 Jun 28.
- PMID: 30025758
- PubMed abstract
- Source abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.
- Weiss A, Garber JE, King T.
- JAMA Surg. 2018 Aug 29. doi: 10.1001/jamasurg.2018.2493. [Epub ahead of print]
- PMID: 30167656
- PubMed abstract
- Source abstract
-
- Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
- Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ.
- JAMA Oncol. 2018 Aug 1;4(8):1066-1072. doi: 10.1001/jamaoncol.2018.0644.
- PMID: 29801090
- PubMed abstract
- Source abstract
Press: Multigene Sequencing Rapidly Replacing BRCA Tests. (Medscape Oncology)
Letter, Comment:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer.
- PMID: 30383137
- PubMed abstract
- Source abstract
Letter, Reply:
Cancer Risk Estimates for Study of Multiple-Gene Testing After Diagnosis of Breast Cancer-Reply.
- PMID: 30383131
- PubMed abstract
- Source abstract
-
- Patients' perspectives and experiences concerning barriers to accessing information about bilateral prophylactic mastectomy.
- Glassey R, O'Connor M, Ives A, Saunders C, kConFab Investigators, O'Sullivan S, Hardcastle SJ.
- Breast. 2018 Aug;40:116-122. doi: 10.1016/j.breast.2018.05.003. Epub 2018 May 11.
- PMID: 29758504
- PubMed abstract
- Source abstract
-
- Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
- Krontiras H, Farmer M, Whatley J.
- Surg Clin North Am. 2018 Aug;98(4):677-685. doi: 10.1016/j.suc.2018.03.004. Epub 2018 May 30.
- PMID: 30005767
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers.
- Honold F, Camus M.
- Medwave. 2018 Jul 9;18(4):e7161. doi: 10.5867/medwave.2018.04.7160.
- PMID: 30052622
- PubMed abstract
-
- 'We've Scared Women': The Growth of Prophylactic Mastectomy.
- Davenport L.
- Medscape. Medscape Oncology. 2018 Jul 3.
- Review, Commentary
- Free Full Text
Press: 'Taking Back Control': The Growth in Prophylactic Mastectomy (Medscape Oncology)
-
- Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.
- Kearton S, Wills K, Bunting M, Blomfield P, James PA, Burke J.
- Fam Cancer. 2018 Jul;17(3):333-344. doi: 10.1007/s10689-017-0047-1.
- PMID: 29039136
- PubMed abstract
- Source abstract
-
- Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
- Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.
- J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21.
- PMID: 29929997
- PubMed abstract
- Source abstract
-
- Nipple-sparing mastectomy in women at high risk of developing breast cancer.
- Lewis RS, George A, Rusby JE.
- Gland Surg. 2018 Jun;7(3):325-336. doi: 10.21037/gs.2018.04.01.
- PMID: 29998082
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Immediate Breast Reconstruction: Comparative Outcome Study of One-Stage Direct-to-Implant and Two-Stage/Tissue Expander Techniques.
- Meshulam-Derazon S, Shay T, Lewis S, Adler N.
- Isr Med Assoc J. 2018 Jun;20(6):340-344.
- PMID: 29911752
- PubMed abstract
-
- Juliet's story: No reconstruction is a post-mastectomy option.
- [No author given]
- FORCE. XRAYS. 2018 May 24.
- Review, Commentary
- Free Full Text
Blog post: I felt empowered by choosing not to have a reconstruction. (Breast Cancer Care)
-
- The Relationship Between Body Image, Gender, Subjective Norms, and the Decision to Undergo Preventive Mastectomy Among Arab and Jewish BRCA Carriers.
- Kardosh M, Bar-Tal Y, Barnoy S.
- Cancer Nurs. 2018 May/Jun;41(3):255-262. doi: 10.1097/NCC.0000000000000503.
- PMID: 28481778
- PubMed abstract
- Source abstract
-
- Risk management decisions in women with BRCA1 and BRCA2 mutations.
- Morgan R, Brown A, Hamman KJ, Sampson J, Naik A, Massimino K.
- Am J Surg. 2018 May;215(5):899-903. doi: 10.1016/j.amjsurg.2018.02.010. Epub 2018 Feb 13.
- PMID: 29499861
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy for the prevention of primary breast cancer.
- Carbine NE, Lostumbo L, Wallace J, Ko H.
- Cochrane Database Syst Rev. 2018 Apr 5;4:CD002748. doi: 10.1002/14651858.CD002748.pub4.
- PMID: 29620792
- PubMed abstract
- Source abstract
Summary: Women should be aware of their true risk of developing breast cancer and the limitations of current evidence when considering risk-reducing mastectomy. (Cochrane Library)
-
- Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
- Müller D, Danner M, Rhiem K, Stollenwerk B, Engel C, Rasche L, Borsi L, Schmutzler R, Stock S.
- Eur J Health Econ. 2018 Apr;19(3):341-353. doi: 10.1007/s10198-017-0887-5. Epub 2017 Apr 5.
- PMID: 28382503
- PubMed abstract
- Source abstract
-
- When BRCA Mutations Meet Complications.
- Clausen AM.
- Global Health NOW. 2018 Mar 20.
-
- Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
- Yamauchi H, Nakagawa C, Kobayashi M, Kobayashi Y, Mano T, Nakamura S, Arai M.
- Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
- PMID: 29019095
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
- Kotsopoulos J, Narod SA.
- Expert Rev Anticancer Ther. 2018 Mar;18(3):199-200. doi: 10.1080/14737140.2018.1424547. Epub 2018 Jan 8.
- PMID: 29308680
- PubMed abstract
- Editorial
- Free Full Text
-
- Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
- Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S.
- JAMA Surg. 2018 Feb 1;153(2):123-129. doi: 10.1001/jamasurg.2017.3422.
- PMID: 28903167
- PubMed abstract
- Source abstract
Commentary:
When is a Little Breast Tissue Too Much?: Nipple-Sparing Risk-Reducing Mastectomy in BRCA Carriers.
- PMID: 28903136
- PubMed abstract
- Source abstract
-
- Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support Intervention.
- St-Pierre D, Bouchard K, Gauthier L, Chiquette J, Dorval M; Centre ROSE.
- J Genet Couns. 2018 Feb;27(1):274-288. doi: 10.1007/s10897-017-0148-x. Epub 2017 Sep 15.
- PMID: 28916957
- PubMed abstract
- Source abstract
-
- The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy.
- Giannakeas V, Narod SA.
- Breast Cancer Res Treat. 2018 Jan;167(1):263-267. doi: 10.1007/s10549-017-4476-1. Epub 2017 Sep 15.
- PMID: 28914396
- PubMed abstract
- Source abstract
-
- Risk-Reducing Mastectomy and Breast Reconstruction: Indications and Evidence for Current Management Strategies.
- Eisemann BS, Spiegel AJ.
- Clin Plast Surg. 2018 Jan;45(1):129-136. doi: 10.1016/j.cps.2017.08.013. Epub 2017 Sep 29.
- PMID: 29080654
- PubMed abstract
- Source abstract
-
- Heightened perception of breast cancer risk in young women at risk of familial breast cancer.
- Glassey R, O'Connor M, Ives A, Saunders C; kConFab Investigators, O'Sullivan S, Hardcastle SJ.
- Fam Cancer. 2018 Jan;17(1):15-22. doi: 10.1007/s10689-017-0001-2.
- PMID: 28501958
- PubMed abstract
- Source abstract
-
- The Preventive Intervention of Hereditary Breast Cancer.
- Cao A, Huang L, Shao Z.
- Adv Exp Med Biol. 2017 [2017 Dec 28];1026:41-57. doi: 10.1007/978-981-10-6020-5_3.
- PMID: 29282679
- PubMed abstract
- Source abstract
-
- Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
- Sherman KA, Kilby CJ, Shaw LK, Winch C, Kirk J, Tucker K, Elder E.
- Breast. 2017 Dec;36:79-85. doi: 10.1016/j.breast.2017.10.001. Epub 2017 Oct 12.
- PMID: 29031121
- PubMed abstract
- Source abstract
-
- Nipple-Sparing Mastectomy and Its Application on BRCA Gene Mutation Carrier.
- Co M, Chiu R, Chiu TM, Chong YC, Lau S, Lee YH, To HM, Kwong A.
- Clin Breast Cancer. 2017 Dec;17(8):581-584. doi: 10.1016/j.clbc.2017.02.001. Epub 2017 Feb 14.
- PMID: 28428099
- PubMed abstract
- Source abstract
-
- [Current German and American guidelines for autologous fat grafting - a transatlantic comparison].
- Broelsch GF, Könneker S, Ipaktchi R, Vogt PM.
- Handchir Mikrochir Plast Chir. 2017 Dec;49(6):408-414. doi: 10.1055/s-0043-118595. Epub 2017 Dec 29.
- PMID: 29287289
- PubMed abstract
- Source abstract
-
- When to Consider Risk-Reducing Mastectomy in BRCA1/BRCA2 Mutation Carriers with Advanced Stage Ovarian Cancer: a Case Study Illustrating the Genetic Counseling Challenges.
- Speight B, Tischkowitz M.
- J Genet Couns. 2017 Dec;26(6):1173-1178. doi: 10.1007/s10897-017-0136-1. Epub 2017 Aug 5.
- PMID: 28780755
- PubMed abstract
- Case report
- Free Full Text
-
- Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. Psychosocial Issues in Inherited Breast and Ovarian Cancer Syndromes. Psychosocial Outcome Studies.
- PDQ Cancer Genetics Editorial Board.
- PDQ Cancer Information Summaries [Internet]. Bethesda, MD: National Cancer Institute. Updated 2017 Nov 30. Accessed 2017 Dec 8.
- PMID: 26389210
- PubMed abstract
- Section link
-
- Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
- Nurudeen S, Guo H, Chun Y, Coopey S, Barry W, Garber J, Dominici LS.
- Am J Surg. 2017 Oct;214(4):687-694. doi: 10.1016/j.amjsurg.2017.06.017. Epub 2017 Jun 28.
- PMID: 28683895
- PubMed abstract
- Source abstract
-
- Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
- Wahner Hendrickson AE, Bakkum-Gamez JN, J Couch F, Ghosh K, Boughey JC.
- Ann Surg Oncol. 2017 Oct;24(11):3107-3109. doi: 10.1245/s10434-017-5999-8. Epub 2017 Jul 20.
- PMID: 28730286
- PubMed abstract
- Editorial
- Free Full Text
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
- PMID: 28699130
- PubMed abstract
- Source abstract
-
- Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.
- Gamble C, Havrilesky LJ, Myers ER, Chino JP, Hollenbeck S, Plichta JK, Kelly Marcom P, Shelley Hwang E, Kauff ND, Greenup RA.
- Ann Surg Oncol. 2017 Oct;24(11):3116-3123. doi: 10.1245/s10434-017-5995-z. Epub 2017 Jul 11.
- PMID: 28699130
- PubMed abstract
- Source abstract
Editorial:
Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
- PMID: 28730286
- PubMed abstract
- Free Full Text
-
- Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.
- Gilbert E, Zabor EC, Stempel M, Mangino D, Heerdt A, Pilewskie M.
- Ann Surg Oncol. 2017 Oct;24(10):3048-3054. doi: 10.1245/s10434-017-5976-2. Epub 2017 Aug 1.
- PMID: 28766223
- PubMed abstract
- Source abstract
-
- Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
- Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, Boughey JC.
- Ann Surg Oncol. 2017 Oct;24(10):3067-3072. doi: 10.1245/s10434-017-5959-3. Epub 2017 Aug 1.
- PMID: 28766224
- PubMed abstract
- Source abstract
-
- Qualitatively understanding patients' and health professionals' experiences of the BRECONDA breast reconstruction decision aid.
- Sherman KA, Shaw LK, Jørgensen L, Harcourt D, Cameron L, Boyages J, Elder E, Kirk J, Tucker K.
- Psychooncology. 2017 Oct;26(10):1618-1624. doi: 10.1002/pon.4346. Epub 2017 Jan 30.
- PMID: 27957772
- PubMed abstract
- Source abstract
-
- Quality of Patient Decisions About Breast Reconstruction After Mastectomy.
- Lee CN, Deal AM, Huh R, Ubel PA, Liu YJ, Blizard L, Hunt C, Pignone MP.
- JAMA Surg. 2017 Aug 1;152(8):741-748. doi: 10.1001/jamasurg.2017.0977.
- PMID: 28467530
- PubMed abstract
-
- Risk Reduction Strategies in Breast Cancer Prevention.
- Costa M, Saldanha P.
- Eur J Breast Health. 2017 Jul 1;13(3):103-112. doi: 10.5152/ejbh.2017.3583. eCollection 2017 Jul.
- PMID: 28894848
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- Managing hereditary breast cancer risk in women with and without ovarian cancer.
- Peters ML, Garber JE, Tung N.
- Gynecol Oncol. 2017 Jul;146(1):205-214. doi: 10.1016/j.ygyno.2017.04.013. Epub 2017 Apr 25.
- PMID: 28454658
- PubMed abstract
- Source abstract
-
- Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.
- Schott S, Vetter L, Keller M, Bruckner T, Golatta M, Eismann S, Dikow N, Evers C, Sohn C, Heil J.
- Arch Gynecol Obstet. 2017 Jun;295(6):1451-1458. doi: 10.1007/s00404-017-4376-y. Epub 2017 Apr 24.
- PMID: 28439664
- PubMed abstract
- Source abstract
-
- Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.
- Skandarajah AR, Thomas S, Shackleton K, Chin-Lenn L, Lindeman GJ, Mann GB.
- Breast. 2017 Apr;32:93-97. doi: 10.1016/j.breast.2017.01.002. Epub 2017 Jan 18.
- PMID: 28107734
- PubMed abstract
- Source abstract
-
- Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
- Tesson S, Richards I, Porter D, Phillips KA, Rankin N, Costa D, Musiello T, Marven M, Butow P.
- Breast. 2017 Feb;31:233-240. doi: 10.1016/j.breast.2016.11.025. Epub 2016 Dec 13.
- PMID: 27969575
- PubMed abstract
- Source abstract
-
- Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers.
- Glassey R, Saunders C, Hardcastle SJ.
- Front Psychol. 2017 Jan 31;8:121. doi: 10.3389/fpsyg.2017.00121. eCollection 2017.
- PMID: 28197122
- PubMed abstract
- Comment
- Free Full Text
Review:
Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers
- PMID: 24612652
- PubMed abstract
- Source abstract
-
- Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.
- van Driel CM, Oosterwijk JC, Meijers-Heijboer EJ, van Asperen CJ, Zeijlmans van Emmichoven IA, de Vries J, Mourits MJ, Henneman L, Timmermans DR, de Bock GH.
- Breast. 2016 Dec;30:66-72. doi: 10.1016/j.breast.2016.08.016. Epub 2016 Sep 14.
- PMID: 27639031
- PubMed abstract
- Source abstract
-
- Prophylactic Bilateral Nipple-sparing Mastectomy and a Staged Breast Reconstruction Technique: Preliminary Results.
- Tondu T, Thiessen F, Tjalma WA.
- Breast Cancer (Auckl). 2016 Nov 9;10:185-189. eCollection 2016.
- PMID: 27867298
- PubMed abstract
- Source abstract
-
- Users' guide to the surgical literature: how to assess an article about harm in surgery.
- Thoma A, Kaur MN, Farrokhyar F, Waltho D, Levis C, Lovrics P, Goldsmith CH.
- Can J Surg. 2016 Sep;59(5):351-357.
- PMID: 27668334
- PubMed abstract
- Source abstract
-
- Trends in Breast Reconstruction by Ethnicity: An Institutional Review Centered on the Treatment of an Urban Population.
- Rodby KA, Danielson KK, Shay E, Robinson E, Benjamin M, Antony AK.
- Am Surg. 2016 Jun;82(6):497-504.
- PMID: 27305880
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy: insights from women who chose to reduce their risk by Andrea Farkas Patenaude, PhD Praeger 2012. 227 ps. ISBN: 0313345163.
- Lisa R. Rubin, Kailey Roberts.
- Psycho-Oncology. 25(6):747-8. doi: 10.1002/pon.4152. 2016 Jun.
-
- Iranian women's attitude toward prophylactic mastectomy for breast cancer.
- Majidzadeh-A K, Farahmand L, Zare AA, Esmaeili R, Salehi M, Habibi M.
- J Cancer Res Ther. 2016 Apr-Jun;12(2):915-9. doi: 10.4103/0973-1482.171363.
- PMID: 27461674
- PubMed abstract
- Source abstract
-
- Is Sentinel Lymph Node Biopsy Necessary in Patients Undergoing Prophylactic Mastectomy? A Systematic Review and Meta-Analysis.
- Nagaraja V, Edirimanne S, Eslick GD.
- Breast J. 2016 Mar-Apr;22(2):158-65. doi: 10.1111/tbj.12549. Epub 2016 Jan 8.
- PMID: 26748493
- PubMed abstract
- Source abstract
-
- Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
- Basu NN, Ingham S, Hodson J, Lalloo F, Bulman M, Howell A, Evans DG.
- Fam Cancer. 2015 Dec;14(4):531-8. doi: 10.1007/s10689-015-9825-9.
- PMID: 26239694
- PubMed abstract
- Source abstract
-
- A Woman's Decision to Choose Bilateral Mastectomy.
- Jerome-D'Emilia B, Suplee PD, Boiler JL, D'Emilia JC.
- Cancer Nurs. 2015 Nov-Dec;38(6):426-35. doi: 10.1097/NCC.0000000000000232.
- PMID: 25643006
- PubMed abstract
- Source abstract
-
- Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
- Manning AT, Wood C, Eaton A, Stempel M, Capko D, Pusic A, Morrow M, Sacchini V.
- Br J Surg. 2015 Oct;102(11):1354-9. doi: 10.1002/bjs.9884. Epub 2015 Aug 27.
- PMID: 26313374
- PubMed abstract
- Source abstract
-
- Podcast: Prophylactic Surgery Decisions Before BRCA Testing.
- [No author given]
- My Gene Counsel. 2015 Sep 29.
- Blog post, Podcast
- Free Full Text
-
- Risk assessment: Physicians discuss motivations for rising rates of prophylactic mastectomies.
- Printz C.
- Cancer. 2015 Jun 1;121(11):1721-2. doi: 10.1002/cncr.28996.
- PMID: 25994526
- PubMed abstract
- Source abstract
- News
- Free Full Text
-
- Bilateral Prophylactic Mastectomy Rarely Cost-effective.
- Pam Harrison.
- Medscape Medical News. American Society of Breast Surgeons (ASBS) 16th Annual Meeting. 2015 May 1.
- Conference report
- Free Full Text
-
- The relationship between the belief in a genetic cause for breast cancer and bilateral mastectomy.
- Petrie KJ, Myrtveit SM, Partridge AH, Stephens M, Stanton AL.
- Health Psychol. 2015 May;34(5):473-6. doi: 10.1037/hea0000118. Epub 2014 Aug 18.
- PMID: 25133845
- PubMed abstract
- Source abstract
-
- A MDP Model for Breast and Ovarian Cancer Intervention Strategies for BRCA1/2 Mutation Carriers.
- Abdollahian M, Das TK.
- IEEE J Biomed Health Inform. 2015 Mar;19(2):720-7. doi: 10.1109/JBHI.2014.2319246. Epub 2014 Apr 22.
- PMID: 24771600
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy: Who needs it, when and why.
- Burke EE, Portschy PR, Tuttle TM.
- J Surg Oncol. 2015 Jan;111(1):91-5. doi: 10.1002/jso.23695. Epub 2014 Jun 25.
- PMID: 24965368
- PubMed abstract
- Source abstract
-
- Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
- Tong A, Kelly S, Nusbaum R, Graves K, Peshkin BN, Valdimarsdottir HB, Wood M, McKinnon W, Garber J, McCormick SR, Jandorf L, Schwartz MD.
- Psychooncology. 2015 Jan;24(1):33-9. doi: 10.1002/pon.3560. Epub 2014 May 17.
- PMID: 24839250
- PubMed abstract
- Source abstract
-
- Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.
- Rhiem K, Schmutzler R.
- Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592.
- PMID: 25759620
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Informed decision-making is the key in women at high risk of breast cancer.
- Taylor A, Tischkowitz M.
- Eur J Surg Oncol. 2014 Jun;40(6):667-9. doi: 10.1016/j.ejso.2014.02.219. Epub 2014 Feb 17.
- PMID: 24655800
- PubMed abstract
- Source abstract
-
- Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers.
- Pilgrim S, Pain S.
- Eur J Surg Oncol. 2014 Jun;40(6):670-2. doi: 10.1016/j.ejso.2014.02.218. Epub 2014 Feb 18.
- PMID: 24612652
- PubMed abstract
- Source abstract
Comment:
Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers.
- PMID: 28197122
- PubMed abstract
- Free Full Text
-
- Changes in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.
- Matloff ET, Bonadies DC, Moyer A, Brierley KL.
- J Genet Couns. 2014 Apr;23(2):164-71. doi: 10.1007/s10897-013-9625-z. Epub 2013 Jul 13.
- PMID: 23852268
- PubMed abstract
- Source abstract
Press: What’s Ahead for BRCA Genetic Testing and Counseling? (OncLive)
-
- Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial.
- Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA, van der Sanden-Melis J, Brouwer T, Hogervorst FB, van der Luijt RB, Valdimarsdottir HB, van Dalen T, Theunissen EB, van Ooijen B, de Roos MA, Borgstein PJ, Vrouenraets BC, Vriens E, Bouma WH, Rijna H, Vente JP, Witkamp AJ, Rutgers EJ, Ausems MG.
- Br J Cancer. 2014 Feb 18;110(4):1081-7. doi: 10.1038/bjc.2013.805. Epub 2014 Jan 14.
- PMID: 24423928
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timing.
- van Driel CM, Eltahir Y, de Vries J, Jaspers JP, Oosterwijk JC, Mourits MJ, de Bock GH.
- Maturitas. 2014 Feb;77(2):180-4. doi: 10.1016/j.maturitas.2013.10.017. Epub 2013 Nov 1.
- PMID: 24268650
- PubMed abstract
- Source abstract
-
- Angelina's choice: private decision, public impact.
- Sirohi B, Sinha N, Goel NS, Badwe RA.
- Indian J Med Ethics. 2014 Jan-Mar;11(1):34-5.
- PMID: 24509107
- PubMed abstract
- Source abstract
-
- Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
- Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O.
- Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi: 10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17.
- PMID: 23333547
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy: an appraisal.
- Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC.
- Am Surg. 2013 Feb;79(2):205-12.
- PMID: 23336662
- PubMed abstract
- Source abstract
-
- Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.
- Hoskins LM, Greene MH.
- Qual Health Res. 2012 Dec;22(12):1633-46. doi: 10.1177/1049732312458182. Epub 2012 Aug 27.
- PMID: 22927701
- PubMed abstract
- Source abstract
-
- 'Cancer doesn't have an age': Genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24.
- Werner-Lin A, Hoskins LM, Doyle MH, Greene MH.
- Health (London). 2012 Nov;16(6):636-54. doi: 10.1177/1363459312442420. Epub 2012 Apr 30.
- PMID: 22547552
- PubMed abstract
- Source abstract
-
- Role of Breast Surgery in BRCA Mutation Carriers.
- Nestle-Krämling C, Kühn T.
- Breast Care (Basel). 2012 Oct;7(5):378-82. doi: 10.1159/000343717.
- PMID: 24647776
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
- Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A.
- Ann Surg Oncol. 2012 Aug;19(8):2600-6. doi: 10.1245/s10434-012-2299-1. Epub 2012 Mar 7.
- PMID: 22396004
- PubMed abstract
- Source abstract
-
- How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
- Watts KJ, Meiser B, Mitchell G, Kirk J, Saunders C, Peate M, Duffy J, Kelly PJ, Gleeson M, Barlow-Stewart K, Rahman B, Friedlander M, Tucker K; TFGT Collaborative Group.
- BMC Cancer. 2012 Jul 28;12:320. doi: 10.1186/1471-2407-12-320.
- PMID: 22838957
- PubMed abstract
-
- [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
- Arai M, Taki K, Iwase H, Takizawa K, Nishimura S, Iwase T.
- Gan To Kagaku Ryoho. 2012 Apr;39(4):525-31.
- PMID: 22504676
- PubMed abstract
- Source abstract
-
- Online tool to guide decisions for BRCA1/2 mutation carriers.
- Kurian AW, Munoz DF, Rust P, Schackmann EA, Smith M, Clarke L, Mills MA, Plevritis SK.
- J Clin Oncol. 2012 Feb 10;30(5):497-506. doi: 10.1200/JCO.2011.38.6060. Epub 2012 Jan 9.
- PMID: 22231042
- PubMed abstract
- Source abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: An Online BRCA Positive Decision Guidance Tool.
Comment:
Are we ready for online tools in decision making for BRCA1/2 mutation carriers?
- PMID: 22231044
- PubMed abstract
- Free Full Text
Press: Are We Ready for Online Tools in Decision Making for BRCA1/2 Mutation Carriers? (Journal of Clinical Oncology)
Press: Online tool helps those with BRCA mutations understand options. (Medical Xpress)
-
- What made her give up her breasts: a qualitative study on decisional considerations for contralateral prophylactic mastectomy among breast cancer survivors undergoing BRCA1/2 genetic testing.
- Kwong A, Chu AT.
- Asian Pac J Cancer Prev. 2012;13(5):2241-7.
- PMID: 22901201
- PubMed abstract
- Source abstract